Skip to content
Screener

Crinetics Pharmaceuticals CRNX Business Segments — External Selling, General And Administrative Expenses

Similar metrics at other companies

Target logo
TGTReportable Segment — Selling, general, and administrative expenses
$5.56B+21.2%
Dollar Tree logo
DLTRReportable Segment — Selling, general and administrative expenses
$1.38B+9.0%
YSS
YSSReportable Segment — Selling, general and administrative expenses
$36.71M+37.0%
Forgent Power Solutions logo
FPSReportable Segment — Selling, general and administrative expenses
$78.52M+145%
YETI Holdings, Inc. logo
YETIReportable Segment — Selling, general, and administrative expenses
$197.77M+9.8%
Five Below logo
FIVEReportable Segment — Selling, general and administrative expenses
$254.91M+20.5%

Other financials

Income statement

See full
Revenue$10.7M+2,873%
Gross profit$10.5M+2,818%
Operating income-$140.4M-26.0%
Net income-$127.8M-32.1%
EPS (diluted)-$1.23-18.3%

Balance sheet

See full
Cash & equivalents$115.1M+20.1%
Total debt$47.9M-5.8%
Total equity$1.3B+2.1%
Total assets$1.4B+2.9%

Cash flow

See full
Operating cash flow-$124.7M-41.0%
CapEx$820.0K-33.8%
Free cash flow-$125.5M-40.0%

Valuation

See full
Market cap$8.9B+233%
Enterprise value$8.84B+231%
P/S492.8×-1,427×

Profitability

See full
Gross margin150%-15.6pp
Operating margin-3,020.3%-1,463pp
Net margin-2,747.2%-1,328pp
FCF margin-2,321.7%-1,122pp

Returns & leverage

See full
Return on equity-39.2%+14.5pp
Debt / equity0.0×
Current ratio18.6×-3.9×

Where this comes from

Reported directly by Crinetics Pharmaceuticals in its filing.

Tagged under the XBRL concept crnx:ExternalSellingGeneralAndAdministrativeExpenses.

The source filing: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:21 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001658247-26-000040
Line itemThree months ended March 31, 2026Three months ended March 31, 2025
Other research and development (1)(8,301)(6,736)
Total research and development expenses(100,081)(76,240)
Selling, general and administrative
Other selling, general and administrative expenses (2)(20,442)(14,774)
Selling, general and administrative personnel expenses(20,037)(12,093)
Selling, general and administrative stock-based compensation(10,352)(8,659)
Total selling, general and administrative expenses(50,831)(35,526)
Total other income, net12,53314,631

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is Crinetics Pharmaceuticals's business segments — external selling, general and administrative expenses?
Crinetics Pharmaceuticals (CRNX) reported business segments — external selling, general and administrative expenses of $20.44M in Q1 2026.
How has Crinetics Pharmaceuticals's business segments — external selling, general and administrative expenses changed year-over-year?
Crinetics Pharmaceuticals's business segments — external selling, general and administrative expenses increased by 38.4% year-over-year, from $14.77M to $20.44M.
What does business segments — external selling, general and administrative expenses mean?
This metric tracks third-party costs associated with selling, general, and administrative functions, such as marketing, legal, and professional services. It reflects the external operational support required to manage the business and prepare for commercial product launches. Monitoring this provides insight into the company's commercial infrastructure and administrative overhead.

Ask your AI about Crinetics Pharmaceuticals's business segments — external selling, general and administrative expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude